Procalcitonin in Pleural Pleuritis

Pleural Empyema Clinical Trial

Official title:

Evaluation de la Mesure du Taux de la Procalcitonine Dans Les Liquides Pleuraux

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01011881
• Other study ID #: PI09-DR-DOUADI
• Status: Completed
• Phase: N/A
• First received: November 10, 2009
• Last updated: June 8, 2016
• Start date: October 2009
• Est. completion date: February 2011

Study information

• Verified date: June 2016
• Source: Centre Hospitalier Universitaire, Amiens
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Institutional Ethical Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine pleural level of procalcitonin in differents situations of pleuritis.

Description:

Determine pleural level of procalcitonin in pleuritis. Two periods First period evaluation in vitro study/ Determine adequat technique included type of samples tubes for adequat analysis.

Second periods : Patient with pleuritis . Empyema or not

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: February 2011
• Est. primary completion date: February 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Pleuritis

• Hospitalisation

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Empyema
• Empyema, Pleural
• Pleural Empyema
• Pleurisy
• Pleuritis

Intervention

Other:
• pleural level of procalcitonin
no intervention

Locations

Country	Name	City	State
France	CHU Amiens	Amiens

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France,